EMA
research
· 2013-07-26
Investigation into GLP-1-based diabetes therapies concluded
Summary
EMA investigation into GLP-1-based diabetes therapies has concluded, summarizing findings without additional regulatory action.
Upgrade for the full analysis, importance score, and drug timeline.